Hjem › Multipelt myelom › California › Santa Monica
Kliniske studier for Multipelt myelom i Santa Monica, CA
8 studier for Multipelt myelom søker deltakere på steder i og rundt Santa Monica (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
RekruttererFase 2
- Beverly Hills Cancer Center (BHCC), Beverly Hills · 6 mi unna
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
RekruttererFase 3
- Research Site, Santa Monica
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- Beverly Hills Cancer Center Clinical Research Advisors LLC, Beverly Hills · 6 mi unna
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RekruttererFase 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mi unna
- Clinical Research Advisors (Encino Satellite Location), Encino · 10 mi unna
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruttererFase 3
- Research Site, Santa Monica
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
RekruttererFase 1
- UCLA Health, Jonsson Comprehensive Cancer Center, Santa Monica
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Beverly Hills Cancer Center /ID# 266921, Beverly Hills · 6 mi unna
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruttererFase 3
- GSK Investigational Site, Beverly Hills · 6 mi unna
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA42 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Edison, NJ22 studier
Andre studier i Santa Monica
- Ikke-småcellet lungekreft45 studier
- Brystkreft28 studier
- Kolorektal kreft23 studier
- Kreft (alle typer)22 studier
- Metastatisk kreft19 studier
- Lungekreft15 studier
- Eggstokkreft15 studier
- Prostatakreft15 studier
- Plateepitelcancer i hode og hals13 studier
- Hjertesvikt11 studier
- Endometriekreft10 studier
- Mavekreft9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.